Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64%
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Investor Relations

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Peter Rothschild M.Sc. Econ., MBA
Founder & Chairman
No Bio Available
Ms. Theresa P. Agnew
CEO & President
No Bio Available
Mr. Alexander Kotsinas M.Sc. (Eng.).
Executive VP & CFO
No Bio Available
Ludvig Milesson
Chief Operating Officer
No Bio Available
Mr. Gianfranco Grompone
Chief Scientific Officer and VP of Research & Development
No Bio Available
Ms. Caroline Mofors
Chief Legal Officer
No Bio Available
Ms. Linda Hagglund
Vice President of Marketing
No Bio Available
Ms. Angelika Kjelldorff
Chief HR Officer
No Bio Available
Sebastian Heimfors
VP & Chief Commercial Officer
No Bio Available
Jonathan Gromark
Sustainability Manager
No Bio Available

Contacts

Address
STOCKHOLM
Stockholm
Kungsbroplan 3
Contacts
+46855529300.0
sv.biogaia.com